SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3,358.05 |
Enterprise Value ($M) | 25,078.05 |
Book Value ($M) | -242.00 |
Book Value / Share | -0.66 |
Price / Book | -13.88 |
NCAV ($M) | -21,431.00 |
NCAV / Share | -58.27 |
Price / NCAV | -0.16 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.01 |
Return on Assets (ROA) | -0.01 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.82 |
Current Ratio | 1.19 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5,351.00 |
Assets | 26,540.00 |
Liabilities | 26,782.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Meruelo Alex | 9.97 | ||
13D/A | Icahn Carl C | |||
13G/A | Goldentree Asset Management Lp | 7.80 | 44.02 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
181,875 | 1,317,725 | 13.80 | |
213,072 | 1,524,143 | 13.98 | |
105,939 | 1,394,962 | 7.59 | |
141,398 | 930,597 | 15.19 | |
(click for more detail) |
Similar Companies | |
---|---|
ADCT – ADC Therapeutics SA | ANRO – Alto Neuroscience, Inc. |
ANVS – Annovis Bio, Inc. | BHVN – Biohaven Ltd. |
BMY – Bristol-Myers Squibb Company |